| Mark Nichols Robinson, | |
|
10099 Ridgegate Pkwy Ste 480, Lone Tree, CO 80124-5537 | |
| (720) 599-3074 | |
| (303) 306-7753 |
| Full Name | Mark Nichols Robinson |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 15 Years |
| Location | 10099 Ridgegate Pkwy Ste 480, Lone Tree, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720206014 | NPI | - | NPPES |
| 71771883 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | DR0047531 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Orthocolorado Hospital At St Anthony Med Campus | Lakewood, CO | Hospital |
| Centura Health-st Anthony Hospital | Lakewood, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Panorama Orthopedics And Spine Center Pc | 8426961087 | 277 |
News Archive
Vertex Pharmaceuticals Incorporated today announced plans to enroll an additional treatment arm as part of its ongoing Phase 2 clinical trial evaluating 12-week regimens of Vertex's lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.
GenoMed announced today that it has submitted a case report of a sickle cell patient whose pain disappeared with GenoMed's treatment approach, only to recur when GenoMed's treatment was stopped.
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, today announced that it has started a major clinical trial to validate the Company's urine-based multi-biomarker self-test, Headstart, for the early detection of exacerbations in patients living with moderate to severe Chronic Obstructive Pulmonary Disease .
Professor Stéphane Lefrançois, a researcher at the Institut National de la Recherche Scientifique (INRS), is working on Batten disease, a neurodegenerative genetic disease that primarily affects children. His research focuses on the most common form of the disease - Batten CLN 3 - which is caused by mutations in the protein of the same name and for which there is still no cure.
According to a latest report released this Monday, Toronto has more HIV and AIDS cases than ever before, with an estimated one in 120 adults in the city now HIV-positive. In all of Ontario, the number of people living with HIV-AIDS grew by 31 per cent between 2003 and 2008 and that number continues to expand.
› Verified 4 days ago
| Entity Name | Panorama Orthopedics And Spine Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295787950 PECOS PAC ID: 8426961087 Enrollment ID: O20031110000424 |
News Archive
Vertex Pharmaceuticals Incorporated today announced plans to enroll an additional treatment arm as part of its ongoing Phase 2 clinical trial evaluating 12-week regimens of Vertex's lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.
GenoMed announced today that it has submitted a case report of a sickle cell patient whose pain disappeared with GenoMed's treatment approach, only to recur when GenoMed's treatment was stopped.
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, today announced that it has started a major clinical trial to validate the Company's urine-based multi-biomarker self-test, Headstart, for the early detection of exacerbations in patients living with moderate to severe Chronic Obstructive Pulmonary Disease .
Professor Stéphane Lefrançois, a researcher at the Institut National de la Recherche Scientifique (INRS), is working on Batten disease, a neurodegenerative genetic disease that primarily affects children. His research focuses on the most common form of the disease - Batten CLN 3 - which is caused by mutations in the protein of the same name and for which there is still no cure.
According to a latest report released this Monday, Toronto has more HIV and AIDS cases than ever before, with an estimated one in 120 adults in the city now HIV-positive. In all of Ontario, the number of people living with HIV-AIDS grew by 31 per cent between 2003 and 2008 and that number continues to expand.
› Verified 4 days ago
| Entity Name | Carepoint Neurosurgery Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275311896 PECOS PAC ID: 2668754805 Enrollment ID: O20170123001993 |
News Archive
Vertex Pharmaceuticals Incorporated today announced plans to enroll an additional treatment arm as part of its ongoing Phase 2 clinical trial evaluating 12-week regimens of Vertex's lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.
GenoMed announced today that it has submitted a case report of a sickle cell patient whose pain disappeared with GenoMed's treatment approach, only to recur when GenoMed's treatment was stopped.
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, today announced that it has started a major clinical trial to validate the Company's urine-based multi-biomarker self-test, Headstart, for the early detection of exacerbations in patients living with moderate to severe Chronic Obstructive Pulmonary Disease .
Professor Stéphane Lefrançois, a researcher at the Institut National de la Recherche Scientifique (INRS), is working on Batten disease, a neurodegenerative genetic disease that primarily affects children. His research focuses on the most common form of the disease - Batten CLN 3 - which is caused by mutations in the protein of the same name and for which there is still no cure.
According to a latest report released this Monday, Toronto has more HIV and AIDS cases than ever before, with an estimated one in 120 adults in the city now HIV-positive. In all of Ontario, the number of people living with HIV-AIDS grew by 31 per cent between 2003 and 2008 and that number continues to expand.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Nichols Robinson, 10099 Ridgegate Pkwy Ste 480, Lone Tree, CO 80124-5537 Ph: (720) 441-4021 | Mark Nichols Robinson, 10099 Ridgegate Pkwy Ste 480, Lone Tree, CO 80124-5537 Ph: (720) 599-3074 |
News Archive
Vertex Pharmaceuticals Incorporated today announced plans to enroll an additional treatment arm as part of its ongoing Phase 2 clinical trial evaluating 12-week regimens of Vertex's lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.
GenoMed announced today that it has submitted a case report of a sickle cell patient whose pain disappeared with GenoMed's treatment approach, only to recur when GenoMed's treatment was stopped.
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, today announced that it has started a major clinical trial to validate the Company's urine-based multi-biomarker self-test, Headstart, for the early detection of exacerbations in patients living with moderate to severe Chronic Obstructive Pulmonary Disease .
Professor Stéphane Lefrançois, a researcher at the Institut National de la Recherche Scientifique (INRS), is working on Batten disease, a neurodegenerative genetic disease that primarily affects children. His research focuses on the most common form of the disease - Batten CLN 3 - which is caused by mutations in the protein of the same name and for which there is still no cure.
According to a latest report released this Monday, Toronto has more HIV and AIDS cases than ever before, with an estimated one in 120 adults in the city now HIV-positive. In all of Ontario, the number of people living with HIV-AIDS grew by 31 per cent between 2003 and 2008 and that number continues to expand.
› Verified 4 days ago
Dr. Bradley Stuart Duhon, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 10099 Ridgegate Pkwy, Suite 310, Lone Tree, CO 80124 Phone: 303-790-1800 Fax: 303-996-7556 | |
Chad J Prusmack, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 10103 Ridgegate Pkwy, Suite 306, Lone Tree, CO 80124 Phone: 303-225-8120 Fax: 303-225-8130 | |
Kevin Louis Boyer, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 10099 Ridge Gate Pkwy, Suite 310, Lone Tree, CO 80124 Phone: 303-790-1800 Fax: 303-790-1809 | |
Michael Joseph Rauzzino, MD, FACS Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 10099 Ridgegate Pkwy Ste 310, Lone Tree, CO 80124 Phone: 303-790-1800 Fax: 303-790-1809 |